Abstract
Myocarditis is a pathologic entity that has serious potential consequences for competitive athletes. Myocarditis is an inflammation of the myocardium accompanied by myocellular necrosis. Cardiotropic viruses, in particular the Coxsackie B virus, have been implicated as the most common cause of acute myocarditis in the United States. A thorough history, physical examination, electrocardiogram, echocardiogram, elevated cardiac enzymes, and an elevated sedimentation rate help make the diagnosis. Athletes recovering from acute myocarditis should abstain from moderate to vigorous activity for 6 months, have normal cardiac function, and have no demonstrable arrhythmia before returning to sports.
Similar content being viewed by others
References and Recommended Reading
Batra AS, Lewis AB: Acute myocarditis. Curr Opin Pediatr 2001, 13:234–239.
Karjalained J, Heikkila J: Incidence of three presentations of acute myocarditis in young men in military service. Eur Heart J 1999, 20:1120–1125.
Haas GJ: Etiology, evaluation, and management of acute myocarditis. Cardiol Rev 2001, 9:88–95. An excellent review article that discusses acute myocarditis and its management.
Maron BJ, Shirano J, Poliac LC, et al.: Sudden death in competitive athletes. Clinical, demographic and pathological profiles. JAMA 1996, 276:199–204.
Philips M, Robinowitz M, Higgins JR, et al.: Sudden cardiac deaths in Air Force recruits. JAMA 1986, 256:2696–2699.
Karjalainen J, Heikkila J, Nieminen MS: Etiology of mild acute infectious myocarditis. Acta Med Scand 1983, 213:65–73.
Pawsat DE, Lee JY: Inflammatory disorders of the heart. Emerg Med Clin North Am 1998, 16:665–681.
Feldman AM, McNamara D: Myocarditis. N Engl J Med 2000, 343:1388–1398.
Felker GM, Boehmer JP, Hruban RH, et al.: Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000, 36:227–232.
McCarthy III RE, Boehmer JP, Hruban RH, et al.: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690–695.
Drucker NA, Newburger JW: Viral myocarditis: diagnosis and management. Adv Pediatr 1997, 44:141–171.
Caforio AL, McKenna WJ: Recognition and optimum management of myocarditis. Drugs 1996, 52:515–525.
Aretz HT, Billingham ME, Edwards WD, et al.: Myocarditis. Am J Cardiovasc Pathol 1986, 1:3–14.
Friman G, Wesslen L: Infections and exercise in high-performance athletes. Immunol Cell Biol 2000, 78:510–522.
Calorie AL, McKenna WJ: Recognition and optimum management of myocarditis. Drugs 1996, 52:515–525.
Bergstrom K, Erikson U, Nordbring F, et al.: Acute non-rheumatic myopericarditis: a follow-up study. Scand J Infect Dis 1970, 2:7–16.
Vikerfors T, Stjerna A, Olcen P, et al.: Acute myocarditis: serologic diagnosis, clinical findings, and follow-up. Acta Med Scand 1988, 223:45–52.
Maron BJ, Isner JM, McKenna WJ: 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: Hypertrophic cardiomyopathy, myocarditis, and other myopericardial diseases and mitral valve prolapse. Med Sci Sports Exerc 1994, 26:(10 Suppl):S261-S267. A landmark article that discusses return-to-play recommendations for athletes with cardiac conditions.
Gerzen P, Granath A, Holmgren B, Zetterquist S: Acute myocarditis: a follow up study. Br Heart J 1972, 34:575–583.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brennan, F.H., Stenzler, B. & Oriscello, R. Diagnosis and management of myocarditis in athletes. Curr Sports Med Rep 2, 65–71 (2003). https://doi.org/10.1007/s11932-003-0015-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11932-003-0015-4